Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide

被引：117

作者：

Glicklich, D ^{[1
]}

Acharya, A ^{[1
]}

机构：

[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Renal, Bronx, NY 10467 USA

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 1998年 / 32卷 / 02期

关键词：

lupus nephritis; cyclophosphamide; mycophenolate mofetil;

D O I：

10.1053/ajkd.1998.v32.pm9708620

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

intravenous (IV) cyclophosphamide has been the treatment of choice for diffuse proliferative glomerulonephritis (DPGN) in patients with systemic lupus erythematosus (SLE), However, there is little guidance in the medical literature about what to do when this therapy fails. Mycophenolate mofetil (MMF), a new immunosuppressive agent, has been used successfully in patients with solid organ transplants and rheumatoid arthritis. We report two patients with diffuse proliferative glomerulonephritis who responded favorably to MMF therapy after IV cyclophosphamide failed. (C) 1998 by the National Kidney Foundation, Inc.

引用

页码：318 / 322

页数：5

共 15 条

[1] THERAPY OF LUPUS NEPHRITIS - CONTROLLED TRIAL OF PREDNISONE AND CYTOTOXIC DRUGS [J].

AUSTIN, HA ;

KLIPPEL, JH ;

BALOW, JE ;

LERICHE, NGH ;

STEINBERG, AD ;

PLOTZ, PH ;

DECKER, JL .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (10) :614-619

[2] Lupus nephritis - Discussion [J].

Berden, JHM ;

Madias, NE ;

Broumand, B ;

Klinger, M ;

Sonkodi, S ;

Nayak, KS ;

Hruby, Z .

KIDNEY INTERNATIONAL, 1997, 52 (02) :538-558

[3] CONTROLLED TRIAL OF PULSE METHYLPREDNISOLONE VERSUS 2 REGIMENS OF PULSE CYCLOPHOSPHAMIDE IN SEVERE LUPUS NEPHRITIS [J].

BOUMPAS, DT ;

AUSTIN, HA ;

VAUGHN, EM ;

KLIPPEL, JH ;

STEINBERG, AD ;

YARBORO, CH ;

BALOW, JE .

LANCET, 1992, 340 (8822) :741-745

[4] Successful mycophenolate mofetil treatment of glomerular disease [J].

Briggs, WA ;

Choi, MJ ;

Scheel, PJ .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (02) :213-217

[5] Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease [J].

Corna, D ;

Morigi, M ;

Facchinetti, D ;

Bertani, T ;

Zoja, C ;

Remuzzi, G .

KIDNEY INTERNATIONAL, 1997, 51 (05) :1583-1589

[6]

Danovitch G, 1996, TRANSPLANTATION, V61, P722

[7] Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans [J].

Dooley, MA ;

Hogan, S ;

Jennette, C ;

Falk, R .

KIDNEY INTERNATIONAL, 1997, 51 (04) :1188-1195

[8]

GOLDBLUM R, 1993, CLIN EXP RHEUMATOL, V11, P5117

[9] Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis - A randomized, controlled trial [J].

Gourley, MF ;

Austin, HA ;

Scott, D ;

Yarboro, CH ;

Vaughn, EM ;

Muir, J ;

Boumpas, DT ;

Klippel, JH ;

Balow, JE ;

Steinberg, AD .

ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) :549-+

[10]

HEBERT LA, 1997, J AM SOC NEPHROL, V8, pA87

← 1 2 →